Table 6.
Multivariable analysis of epidemiological and clinical variables related to OGD resolution at the end of the follow-up period (T3).
| Model 1 (HRS) |
Model 2 (CCS) |
|||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p | HR | 95% CI | p | |
| Age (years) | 0.99 | 0.97–1.01 | 0.361 | 0.99 | 0.96–1.01 | 0.232 |
| Seasonal influenza vaccination (yes vs no) | 2.33 | 1.10–4.95 | 0.027 | 2.42 | 1.14–5.14 | 0.021 |
| General sign and symptoms (yes vs no) | 0.54 | 0.29–1.01 | 0.053 | 0.54 | 0.29–1.00 | 0.051 |
| HRS | 0.93 | 0.88–0.98 | 0.009 | – | – | – |
| CCS | – | – | – | 0.86 | 0.79–0.94 | 0.001 |
HR, Hazard Ratio; CI, Confidence Interval; HRS, Hyposmia Rating Scale; CCS, Chemosensory Complaint Score.